William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 611 shares at $20.76 ($13K) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Seasonal sale ($13k) by Chief Financial Officer — this insider has traded AKRO in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |